Alexandr V. Golomidov

Alexandr V. Golomidov

Auto-generated profile, based on publicly available information

Alexandr V. Golomidov

S.V. Belyaev Kuzbass Regional Clinical Hospital

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2017 in Messenger of ANESTHESIOLOGY AND RESUSCITATION
Verified
Journal Article
Open access
KHKemerovo Regional Pediatric Clinical Hospital
Kemerovo Regional Pediatric Clinical Hospital
AZA. A. Zаdvornov
A. A. Zаdvornov
АGА. V. Golomidov
А. V. Golomidov
EGEvgeny Grigoryev
Evgeny Grigoryev
KCKemerovo Kuzbass Cardiology Center
Kemerovo Kuzbass Cardiology Center

20 December 2022 in General Reanimatology
Verified
Journal Article
Open access
PDF file
AGA. V. Golomidov
A. V. Golomidov
EGE. V. Grigoriev
E. V. Grigoriev
VMV. G. Moses
V. G. Moses
KMK. B. Moses
K. B. Moses
Multiple organ failure (MOF) is the leading cause of neonatal mortality in intensive care units. The prevalence of MOF in newborns is currently unclear, since its incidence varies in asphyxia, sepsis, prematurity, and comorbidity, and depends on the level of development and funding of health care in different countries. Sepsis and acute respiratory distress syndrome prevail among the causes of MOF in this category of patients.Aim of the review. To summarize the available literature data on the pathogenesis, therapeutic strategies and outcomes of MOF in newborns.Material and methods. We searched PubMed, Scopus, Web of Science, and RSCI databases using the following keywords: «newborns, multiple organ failure, etiology, pathogenesis, premature, diagnosis, treatment, respiratory support, cardiotonic support», without language limitations. A total of 144 full-text sources were selected for analysis, 70% of which were published in the last five years and 50% were published in the last three years. Criteria for exclusion were low information value and outdated data.Results. The prevalence of MOF in neonates is currently unclear. This could be due to common association of neonatal MOF (as well as the adult one) with various diseases; thus, its incidence is not the same for asphyxia, sepsis, prematurity, and comorbidities. There is no precise data on neonatal mortality in MOF, but according to some reports, it may be as high as 13-50%.In newborns, MOF can be caused by two major causes, intrapartum/postnatal asphyxia and sepsis, but could also be influenced by other intranatal factors such as intrauterine infections and acute interruption of placental blood flow.The key element in the pathogenesis of neonate MOF is cytokinemia, which triggers universal critical pathways. Attempts to identify different clinical trajectories of critical illness in various categories of patients have led to the discovery of MOF phenotypes with specific patterns of systemic inflammatory response. This scientific trend is very promising for the creation of new classes of drugs and individual therapeutic pathways in neonates with MOF of various etiologies.The pSOFA scale is used to predict the outcome of neonatal MOF, however, the nSOFA scale has higher validity in premature infants with low birth weight.Central nervous system damage is the major MOF-associated adverse outcome in newborns, with gestational age and the timing of treatment initiation being key factors affecting risk of MOF development in both full-term and premature infants.Conclusion. The study of cellular messengers of inflammation, MOF phenotypes, mitochondrial insufficiency, and immunity in critically ill infants with MOF of various etiologies is a promising area of research. The pSOFA scale is suggested for predicting the outcome of MOF in full-term infants, while the nSOFA scale should be used in premature infants with low birth weight.

1 January 2021 in Neonatology: News, Opinions, Training
Verified
Journal Article
Closed access
AMA.I. Makulova
A.I. Makulova
CSChildren’s City Clinical Hospital No. 9 Named After G.N. Speransky
Children’s City Clinical Hospital No. 9 Named After G.N. Speransky
LZL.S. Zolotareva
L.S. Zolotareva
SAS.V. Aborin
S.V. Aborin
AGA.V. Golomidov
A.V. Golomidov
IUI.M. Sechenov First Moscow State Medical University of Ministry of Healthcare of the Russian Federation (Sechenov University)
I.M. Sechenov First Moscow State Medical University of Ministry of Healthcare of the Russian Federation (Sechenov University)

26 September 2025 in Russian Journal of Pediatric Surgery, Anesthesia and Intensive Care
Verified
Journal Article
Open access
PDF file
AGAlexandr V. Golomidov
Alexandr V. Golomidov
EGEvgeny Grigoryev
Evgeny Grigoryev
VMVadim G. Mozes
Vadim G. Mozes
KMKira B. Mozes
Kira B. Mozes
ГВГригорьев Евгений Валерьевич
Григорьев Евгений Валерьевич
Neonatal sepsis remains a significant cause of mortality and long-term complications in newborns. However, evidence-based approaches to the rehabilitation of children surviving sepsis remain insufficiently developed, highlighting the need to synthesize available data. This review summarizes current evidence on the long-term outcomes and rehabilitation opportunities in children who experienced sepsis during the neonatal period. A scientific data search covering 2019–2024 was conducted in PubMed and eLibrary.ru databases using keywords related to rehabilitation, sepsis, and neonates. After removing duplicates and applying multi-stage screening for relevance to the review topic, 55 publications were included for analysis. The review revealed a high risk of long-term multi-organ sequelae after neonatal sepsis, including neurological impairments (cognitive deficits, cerebral palsy), sensory deficits, bronchopulmonary dysplasia, and cardiovascular dysfunction. It also highlights the lack of unified criteria and methodology for diagnosing neonatal sepsis, as well as protocols for assessing immediate and long-term outcomes in newborns who survived sepsis, and convincing evidence regarding the effectiveness of specific rehabilitation methods. The challenge of implementing modern rehabilitation in neonates is emphasized, since most existing scientific and practical approaches are based on extrapolation of data obtained from the rehabilitation of preterm infants or patients with other conditions, and are not supported by high-quality randomized controlled trials specifically in the population of children after sepsis. The review outlines the current three-stage rehabilitation model (in the intensive care unit, during inpatient care, and in outpatient settings) and discusses several key directions: neurorehabilitation (neuroprotective agents, kinesiotherapy, sensory integration), nutritional support (enriched feeding, optimization of protein–energy balance, prebiotics and probiotics), and psychological support (family-centered early intervention model). Promising approaches that require further investigation include novel neuroprotective agents (xenon, darbepoetin, topiramate, melatonin, caffeine, metformin, hydrocortisone, RLS-0071, stem cells, and sovateltide) and mesenchymal stromal cell secretome therapies. Despite the importance of this issue, the rehabilitation of children after neonatal sepsis remains a field with a low level of evidence. This review systematizes the available evidence, highlights the need for further research to develop evidence-based rehabilitation programs, and to establish individualized rehabilitation trajectories aimed at improving long-term outcomes and quality of life in neonates.

10 February 2020 in Pediatria. Journal named after G.N. Speransky
Verified
Journal Article
Closed access
MHMoscow Saint Vladimir Moscow City Children'S Clinical Hospital
Moscow Saint Vladimir Moscow City Children'S Clinical Hospital
AMA.I. Makulova
A.I. Makulova
LZL.S. Zolotareva
L.S. Zolotareva
IKI.V. Kuznetsova
I.V. Kuznetsova
DDD.N. Degtyarev
D.N. Degtyarev
AMA.A. Mikheeva
A.A. Mikheeva
Облако Mail.ru - это ваше персональное надежное хранилище в интернете.

30 March 2022 in Innovative Medicine of Kuban
Verified
Journal Article
Open access
PDF file
AGA. V. Golomidov
A. V. Golomidov
EGEvgeny Grigoryev
Evgeny Grigoryev
VMV. G. Moses
V. G. Moses
KMK. B. Moses
K. B. Moses
There are several directions for predicting multiple organ dysfunction syndrome (MODS), but almost all of them are poorly tested in neonatology. This review is presented to indicate the problem of the condition severity objectification of newborns and the possibility of predicting the development of MODS. Scales for assessing the severity of MODS in critically ill children have been developed and used since the end of the last century, but their validation in the newborns faces certain difficulties. Prognostic nosospecific scales: NICHD (National Institute of Child Health and Human Development) calculator, CRIB II (Clinical Risk Index for Babies), SNAPPE-II (Score for Neonatal Acute Physiology with Perinatal Extension II) are used in neonatology, however their comparison in this category of patients has not been carried out.Theoretical and practical issues of the short-term and long-term prediction of the MODS onset and its outcomes in newborns is a promising area of neonatology, since it allows a doctor to be warned about an impending catastrophe and opens a “window of opportunity” for timely correction of treatment tactics and complications prevention. Obtaining different phenotypes of critical illness and predicting their outcomes in children may have good predictive potential, but such studies have not been conducted in newborns. A promising direction in predicting MODS is the identification of biomarkers of inflammation, among which endocan, cluster of differentiation 64, cluster of differentiation molecules 11b, “pancreatic stone protein” (PSP), soluble intercellular adhesionmolecule-1 (sICAM-1), progranulin, neopterin, resistin (FIZZ3, presepsin (PSP)) carry a good potential, but their effectiveness in neonatology is still to be investigated.Thus, the prediction of MODS in children and newborns remains an unresolved problem. At the same time, several promising scientific directions are actively being developed today, which may lead to a significant breakthrough in predicting MODS in neonatology.